Attenuation of endothelium-dependent dilation of pig pulmonary arterioles after cardiopulmonary bypass is prevented by monoclonal antibody to complement C5a
Kw. Park et al., Attenuation of endothelium-dependent dilation of pig pulmonary arterioles after cardiopulmonary bypass is prevented by monoclonal antibody to complement C5a, ANESTH ANAL, 89(1), 1999, pp. 42-48
Citations number
27
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
We examined whether pulmonary endothelial dysfunction associated with cardi
opulmonary bypass (CPB) may be mediated by complement Cia in pigs, Pigs Mer
e placed on normothermic CPB for 1 h with or without a previous administrat
ion of 1.6 mg/kg anti-C5a monoclonal antibody (MAb), then reperfused for 2
h. Pulmonary tissue myeloperoxidase activity was measured. Expression of ni
tric oxide synthase (NOS) was measured by reverse transcriptase polymerase
chain reaction and Western blotting. Pulmonary arterioles approximately 100
mu m in diameter were preconstricted with the thromboxane analog U46619 1
mu M, and relaxation responses to adenosine diphosphate 10(-9)-10(-4) RI, s
ubstance P 10(-12)-10(-6) M, and sodium nitroprusside 10(-9)-10(-4) hi were
examined in vitro by videomicroscopy. Relaxation to the endothelium-depend
ent dilators adenosine diphosphate and substance P was attenuated after CPB
; this attenuation was prevented by the previous administration of MAb. Rel
axation to sodium nitroprusside was not;affected by CPB, Neutrophil sequest
ration, as measured by MPO activity, increased after CPB, either with or wi
thout MAb. Transcription of NOS was unchanged by CPB, but translation of co
nstitutive NOS was decreased after CPB, and this decrease was prevented by
a Previous administration of MAb, We conclude that pig pulmonary endothelia
l dysfunction associated with CPB may be mediated by C5a. The mechanism may
involve changes in NOS translation. Implications: In Figs, pulmonary endot
helial dysfunction may occur after cardiopulmonary bypass due to product(s)
of complement activation.